ACI
MRNA icon

AMP Capital Investors’s Moderna MRNA Stock Holding History

AMP Capital Investors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-95,398
Closed -$36.7M – 692
2021
Q3 		$36.7M Sell
95,398
-29,308
-24% -$10.8M 0.2% 122
2021
Q2 		$29.3M Buy
124,706
+19,434
+18% +$3.47M 0.14% 168
2021
Q1 		$13.6M Buy
105,272
+22,910
+28% +$3.32M 0.07% 314
2020
Q4 		$9.15M Buy
82,362
+16,002
+24% +$1.62M 0.05% 412
2020
Q3 		$4.68M Buy
66,360
+7,350
+12% +$512K 0.03% 547
2020
Q2 		$3.66M Buy
+59,010
New +$3.23M 0.02% 587

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AMP Capital Investors's MRNA Position: Q4 2021 in Review

AMP Capital Investors sold out of Moderna (MRNA) in Q4 2021, closing a stake of 95,398 shares — an estimated $36.7M sold.

AMP Capital Investors first reported a position in MRNA in Q2 2020 and held it in 6 quarters. The position peaked at $36.7M in Q3 2021. 1,110 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • AMP Capital Investors reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 95,398 Moderna shares in Q4 2021, an estimated $36.7M.
  • AMP Capital Investors first reported a position in Moderna in Q2 2020 and held it in 6 quarters.
  • AMP Capital Investors's Moderna position peaked at $36.7M in Q3 2021.
  • 1,110 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.